M1A.46

Clinical Causes: Prolonged elevated levels of uric acid in the blood (hyperuricemia) leading to crystal deposition. Chronic inability to eliminate uric acid efficiently via the kidneys or due to increased production. Persistent joint stress or injury that exacerbates crystal accumulation. Underlying health conditions such as obesity, hypertension, or renal impairment. Certain medications that interfere with uric acid elimination, like diuretics.

Key Symptoms: Persistent swelling and inflammation in the knee. Recurrent episodes of pain, often worse during the night or early morning. Reduced joint mobility and stiffness over time. Formation of tophi, which are nodular deposits of uric acid crystals around the joint. Discomfort during movement or weight-bearing activities. Potential joint deformity and erosion if left untreated.

Diagnosis Path: Blood tests to measure serum uric acid levels, which often are elevated. Joint fluid analysis, where fluid from the knee is examined under a microscope for uric acid crystals. Imaging studies such as X-rays may reveal joint erosion, tophi, or other degenerative changes associated with chronic gout. Assessment of kidney function to understand uric acid elimination capacity.

Treatment Protocols: Medications to lower uric acid, such as allopurinol or febuxostat. Anti-inflammatory drugs, like colchicine, NSAIDs, or corticosteroids, to reduce joint inflammation during flare-ups. Lifestyle modifications including dietary changes to reduce intake of purine-rich foods, alcohol, and sugary drinks. Maintaining a healthy weight to decrease stress on the knee joint and improve uric acid metabolism. Regular monitoring of uric acid levels and kidney function. Physical therapy and joint support measures to enhance mobility and reduce discomfort.